Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in ...

Diliman have developed an analytical model that could detect early signs of metastasis, or spread of tumor, in breast cancer ...

Breast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment ...

Researchers at the University of Turku, Finland, have developed a new fluorescent probe to visualize signaling dynamics in ...

(EBC) patients receiving Kisqali in 1-year post-treatment analysis 1 Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients 1 ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...